Skip to Content

'
Dejka M. (Steinert) Araujo, M.D.

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
P.O. Box 301402, Unit 450
Unit Number: 450
Houston, TX 77230-1402

Education & Training

Degree-Granting Education

1999 University of Arkansas for Medical Sciences, Little Rock, AR, MD, Medical Sciences
1995 Notre Dame, Notre Dame, IN, BA, Theology

Postgraduate Training

2002-2005 Clinical Fellowship, The University of Texas MD Anderson Cancer Center, Houston, TX
2000-2002 Clinical Residency, University of Alabama, Birmingham, AL
1999-2000 Clinical Internship, University of Alabama, Birmingham, AL

Board Certifications

11/2007 Medical Oncology

Experience/Service

Academic Appointments

Fellowship Program Director, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 8/2011-present
Associate Faculty Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, 10/2009-present
Quality Officer, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2009-present
Assistant Professor, Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2005-8/2011

Institutional Committee Activities

Member, Clinical Competency Committee of the Hematology/Oncology Fellowship Program, 7/2013-present
Member, Graduate Medical Education Institutional Review Subcommittee, 3/2012-present
Sarcoma Medical Oncology Representative, M.D. Anderson Cancer Center Fellowship Executive Committee, 4/2006-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Conter HJ, Gopalakrishnan V, Ravi V, Ater JL Patel S, Araujo DM. Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience. Sarcoma, 6/2014.
2. Pappo AS, Vassal G, Crowley JJ, Bolejack V, Hogendoorn PC, Chugh R, Ladanyi M, Grippo JF, Dall G, Staddon AP, Chawla SP, Maki RG, Araujo DM, Geoerger B, Ganjoo K, Marina N, Blay JY, Schuetze SM, Chow WA, Helman LJ. A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study. Cancer. e-Pub 5/2014. PMID: 24797726.
3. Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KK. Analysis of Prognostic Factors Impacting Oncologic Outcomes After Neoadjuvant Tyrosine Kinase Inhibitor Therapy for Gastrointestinal Stromal Tumors. Ann Surg Oncol. e-Pub 3/2014. PMID: 24639192.
4. Subbiah V, Westin SN, Wang K, Araujo D, Wang WL, Miller VA, Ross JS, Stephens PJ,. Targeted therapy by combined inhibition of the RAF and mTOR kinases in malignant spindle cell neoplasm harboring the KIAA1549-BRAF fusion protein. J. Hematol Oncol. 14(7(1)):8, 1/2014. e-Pub 1/2014.
5. Dumont SN, Araujo DM, Munsell MF, Salganick JA, Dumont AG, Raymond KA, Linassier C, Patel S, Benjamin RS, Trent JC. Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients. Cancer Med 2(4):553-63, 8/2013. e-Pub 7/2013. PMCID: PMC3799290.
6. Park MS, Ravi V, Conley A, Patel SR, Trent JC, Lev DC, Lazar AJ, Wang WL, Benjmain RS, Araujo DM. The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis. Clinical Sarcoma Research, 5/2013. e-Pub 5/2013.
7. Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Soslow RA, Baker LH. Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: Results of a phase 2 trial (SARC 005). Cancer 119(8):1555-61, 4/2013. e-Pub 1/2013. PMID: 23335221.
8. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE, Lazar AJ, Wang WL. Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model. Modern Pathology 25(9):1298-306, 9/2012.
9. Katz D, Boonsirikamchai P, Choi H, Lazar AJ, Wang WW, Xiao L, Park MS, Ravi V, Benjamin RS, Araujo DM. Efficacy of first-line doxorubicin and ifosfamide in myxoid liposarcoma. Clinical Sarcoma Research 2(1):2, 1/2012.
10. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lin PP, Guadagnolo A, Lòpez-Terrada D, Dei Tos AP, Lewis VO, Lev D, Pollock RE, Zagars GK, Benjamin RS, Madewell JE, Lazar AJ. Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy. Clin Sarcoma Res 2(1):25, 2012. e-Pub 12/2012. PMCID: PMC3599544.
11. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer, 11/2011. PMID: 21480200.
12. Yang J, Yang D, Sun Y, Sun B, Wang G, Trent J, Araujo D, Chen K, Zhang W. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma. Cancer 117(21):4925-38, 11/2011.
13. Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD, Sturgis EM. Outcomes after defininitive treatment of cutaneous angiosarcoma of the face and scalp. Head Neck 33(5):661-7, 5/2011.
14. Shinder R, Jackson TL, Araujo D, Prieto VG, Guadagnolo BA, Esmaeli B. Preoperative Radiation Therapy in the Management of Recurrent Orbital Hemangiopericytoma. Ophthal Plast Reconstr Surg, 1/2011. PMID: 21242853.

Invited Articles

1. Park MS, Ravi V, Araujo DM. Inhibiting the VEGF-VEGFR Pathway in Angiosarcoma, Epithelioid Hemangioendothelioma, and Hemangiopericytoma/Solitary Fibrous Tumor. Current Opinion in Oncology 22(4):351-355, 7/2010.
2. Park MS, Araujo DM. New insights into the hemangiopericytoma/solitary fibrous tumor spectrum of tumors. Current Opinion in Oncology 21(4):327-31, 7/2009. PMID: 19444101.
3. Steinert DM, Patel SR. Recent studies in novel therapy for metastatic sarcomas. Hematol Oncol Clin North Am 19(3):573-90, viii, 6/2005. PMID: 15939198.
4. Steinert DM, Blakely LJ, Salganick J, Trent JC. Molecular targets in therapy for human soft-tissue and bone sarcomas. Curr Oncol Rep 5(4):295-303, 7/2003. PMID: 12781071.

Abstracts

1. Somaiah N, Gomes DBD, Madewell JE, Wang WL, Conley AP, Ravi V, Araujo DM, Ludwig JA, Benjamin RS, Patel S. Defining the chemotherapy (CT) response in well-differentiated (WD) and dedifferentiated (DD) liposarcomas (LPS) of the retroperitoneum (RP): A tertiary referral cancer center experience. J Clin Oncol 32(5s):suppl; abstr 10583, 2014.
2. Subbiah V, Agarwal R, Filip J, Tsimberidou AM, Patel S, Benjamin RS, Ludwig JA, Anderson PM, Araujo DM, Ravi V, Conley AP, Somaiah N, Wang WL, Naing A, Zinner R, Hong DS, Meric-Bernstam F. Diversity and heterogeneity in molecular analysis of advanced sarcomas: The clinical, regulatory, and financial challenge for drug development and precision in medicine. J Clin Oncol 32(5s):suppl; abstr 10595, 2014.
3. Vadhan-Raj S, Zhou X, Araujo DM, Somaiah N, Conley AP, Ravi V, Daniel M, Benjamin RS, Patel S. Effects of fosaprepitant (Fosa) administered as single dose versus two doses, on nausea/vomiting (N/V) in patients receiving multiday chemotherapy (CT) with a highly emetogenic regimen of doxorubicin and ifosfamide (AI): Randomized cross-over study 32(5s):suppl; abstr 9616, 2014.
4. Gupta R, Ramesh N, Rose EJ, Carter K, Araujo DM, Benjamin RS, Patel S, Nates JL, Ravi V. Survival and outcomes of critically ill sarcoma patients admitted to the intensive care unit. J Clin Oncol 32(5s):suppl; abstr 10576, 2014.
5. Williams LA, Araujo DM, Quiling S, Ali NN, Ahaneku H, Jing K, Trent JC, Cleeland CS. Symptoms in gastrointestinal stromal tumors. J Clin Oncol 32(5s):suppl; abstr 9637, 2014.
6. Abouharb S, Warneke CL, Ravi V, Ludwig JA, Lazar AJF, Patel S, Benjamin RS, Araujo DM. Synovial sarcoma: Evaluation of response to treatment with gemcitabine and docetaxel. J Clin Oncol 32(5s):suppl; abstr 10564, 2014.
7. Ravi V, Ramesh N, Patnana M, Conley AP, Somaiah N, Zarzour MA, Ingram D, Little L, Protopopov A, Lazar AJF, Araujo DM, Torres KE, Patel S, Zhang J, Ali SM, Miller VA, Stephens PJ, Benjamin RS, Hwu P, Futreal A. Whole-exome and targeted sequencing of angiosarcomas: Target identification and treatment implications. J Clin Oncol 32(5s):suppl; abstr 10512, 2014.
8. Hensley ML, Wathen K, Maki RG, Araujo DM, Sutton GP, Priebat DA, George S, Baker LH. 3-year follow-up of SARC005: Adjuvant treatment og high risk primary uterine leiomyosarcoma with gemcitabine/docetaxel (GT), followed by doxorubicin (D). CTOS(Poster #78):38, 10/2011.
9. Trent JC, Salganick JA, Thall PF, Patel SR, Araujo DM, Benjamin RS. Efficacy and safety of low-dose protracted irinotecan in patients with advanced sarcomas: results from a phase II study. CTOS - Oral Presentation:90, 10/2011.
10. Demicco E, Park M, Araujo D, Bassett R, Lazar AJ, Wang WL,. Solitary fibrous tumor/hemangiopericytoma: clinicopathologic predictors of outcome. CTOS(Poster # 205):55, 10/2011.
11. Dumont SN, Trent JC, Patel S, Araujo DM, Dumont AG, Benjamin RS. A phase II study of low-dose protracted irinotecan in patients with advanced sarcomas. ASCO (#10064), 6/2011.
12. Gao J, McAuliffe JC, Lazar AJF, Wang W, Choi H, Hunt K, Araujo DM, Pollock RE, Benjamin RS, Trent JC. Mechanism of early radiographic response to imatinib in GIST. ASCO (#10049), 6/2011.
13. Park MS, Patel S, Ravi V, Conley AP, Trent JC, Lazar AJF, Lev D, Wang X, Benjamin RS, Araujo DM. The role of chemotherapy in advanced hemangiopericyoma/solitary fibrous tumor. ASCO (#10097), 6/2011.
14. Ravi V, Yang J, Araujo DM, Park MS, Benjamin RS, Zhang W, Trent JC, Patel S. The role of E-cadherin expression in response and outcome in patients with leiomyosarcoma treated with chemotherapy. ASCO (#10096), 6/2011.
15. Hensley ML, Wathen K, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Baker LH,. Adjuvant Treatment of High-Risk Primary Uterine Leiomyosarcoma with Gemcitabine/Docetaxel (GT), Followed by Doxorubicin (D): Results of Phase II Multicenter Trial SARC005. ASCO (#10021), 2010.
16. Dumont SN, Araujo DM, Dumont AG, Conley AP, Reynoso DG, Raymond K, Munsel MF, Patel S, Benjamin RS, Trent JC. Adult Rhabdomyosarcoma: 239 Patients Followed at MD Anderson Cancer Center. CTOS Oral Presentation (#899871), 2010.
17. Katz D, Boonsirikamchai P, Benjamin RS, Patel S, Ludwig JA, Trent JC, Xiao L, Ravi V, Choi H, Araujo DM. Efficacy of Neoadjuvant Doxorubicin and Ifosfamide (AI) in Myxoid/Round Cell Liposarcoma (MRCL): The M.D. Anderson Cancer Center Experience (MDACC). ASCO (#10080), 2010.
18. Wang WL, Katz D, Araujo DM, Ravi V, Ludwig JA, Trent JC, Patel SR, Lewis VO, Lin P, Pollock RE, Guadagnolo A, Zagars G, Benjamin RS, Madewell JE, Lazar AJ. Extensive fatty maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosamide and pre-operative radiation therapy. CTOS, 2010.
19. Ravi V, Wang W, Araujo DM, Ludwig JA, Luke RJ, Lewis VO, Trent JC, Benjamin RS, Patel S. Imatinib in the Treatment of Tenosynovial Giant-Cell Tumor and Pigmented Villonodular Synovitis. ASCO (#10011), 2010.
20. Park MS, Patel S, Trent JC, Wang W, Conley AP, Benjamin RS, Araujo DM. Multidisciplinary Management of Patients with Primary Pulmonary Artery Sarcoma (PPAS). ASCO (#e20501), 2010.
21. Park MS, Patel SR, Trent JC, Wang WL, Conley AP, Benjamin RS, Araujo DM. Multidisciplinary management of patients with primary pulmonary artery sarcoma (PPAS). CTOS (#899148), 2010.
22. Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Choi H, Benjamin RS, Araujo DM. Combination therapy with temozolamide and bevacizumab in the treatment of hemangiopericytoma/malignant solitary fibrous tumor. ASCO (#10512), 2008.

Book Chapters

1. Steinert DM, Trent JC:. Gastrointestinal stromal tumors. In: Ajani JA, Curley SA, Janjan NA, Lynch PM Gastrointestinal Cancer. 3, M.D. Anderson Cancer Care Series. Ed(s) Buzdar AU, Freedman RS. Springer Science + Business Media, Inc: New York, 2005.

Last updated: 7/3/2014